Atlas Trials

Lapatinib Ditosylate in Treating Patients With Ductal Breast Carcinoma In Situ

Clinical trial NCT00555152 · COMPLETED

Trial details

NCT number
NCT00555152
Sponsor
National Cancer Institute (NCI)
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Ductal Breast Carcinoma In SituHER2/Neu Positive
Start date
2009-08-19
Primary completion
2014-08-28
Enrollment
22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.